Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials in Denmark
2 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleOpen-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
- Where
- Aalborg, Aarhus N, Copenhagen Nv, Copenhagen Oe, Odense C
- Age
- 18 years to 85 years
- People
- 900 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00 - Phase 4Taking peopleTreatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
- Where
- Aarhus, Odense C, Roskilde, Regional Hospital Viborg
- Age
- 18 years and over
- People
- 100
- Run by
- Morten Steen Kvistholm Jensen
See details and how to joinNCT05569382 · EU 2024-515346-17-00